Navigation Links
Biomira Selects PX-866 as Clinical Development Candidate and,Presents Promising Preclinical Data at AACR

of programmed cell death, was observed and PX-866 also inhibited invasive and angiogenic capabilities of cultured glioma cells. In animals, PX-866 inhibited subcutaneous tumor growth by 84 percent after 4 weeks of oral dosing and increased median survival of animals with intracranial tumors. The authors conclude that PX-866 is a highly promising PI3 kinase inhibitor in glioblastomas and other tumors with aberrant PTEN/PI3K expression, which include advanced ovarian, breast and prostate cancers, as well as lung and head and neck cancers.

Dr. Koul and colleagues at MDACC conducted the studies in collaboration with Dr. Lynn Kirkpatrick, Biomira's Chief Scientific Officer, under a grant from the U.S. National Institutes of Health.

About PX-866

PX-866 is an inhibitor of the phosphatidylinositol-3-kinase (PI3 kinase)/PTEN/AKT pathway, an important survival signaling pathway that is activated in many types of human cancer. PI3 kinase is overexpressed in a number of human cancers, especially ovarian, colon, head and neck, urinary tract, and cervical cancers, where it leads to increased proliferation and inhibition of apoptosis (programmed cell death). In preclinical studies, PX-866 has been shown to induce prolonged inhibition of tumor PI3 kinase signaling following both oral and intravenous administration. The compound also has been shown to have good in vivo anti-tumor activity in tumor models of human ovarian and lung cancer, as well as intracranial glioblastoma.

About Biomira

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.

Forward-Looking Statements

This press release contains forward-looking statements, including, without limitation, statements related to the pre-
'"/>




Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... systems, announced today that the United States Food and ... Drug application(IND) for ORMD-0801, its oral insulin capsule. ... clearance to proceed," stated Nadav Kidron ... major milestone for Oramed and we look forward to ...
(Date:5/16/2013)... N.J. , May 16, 2013  PTC Therapeutics, ... statement on Form S-1 with the U.S. Securities and ... offering of its common stock. The number of shares ... offering have not been determined. (Logo:  ... Suisse are acting as joint book-running managers for the ...
(Date:5/16/2013)...  Amgen (NASDAQ: AMGN ) will participate in ... 2013, at the Sheraton New York Times Square in ... Eastern Daylight Time. Joseph P. Miletich , ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Healthcare Products Association (CHPA) today applauded the Alabama ... bill that significantly improves Alabama,s methamphetamine enforcement laws ... for meth-related crime and enhancements to the state,s ... called the National Precursor Log Exchange (NPLEx), successfully ...
... Colo., April 20, 2012  Results from the combined ... presented today at the 3rd European Lung Cancer ... was performed on serum samples from advanced non-squamous ... the combination therapy bevacizumab plus erlotinib.  Results showed ...
Cached Medicine Technology:CHPA Applauds Alabama Senate's Passage of Anti-Meth Bill 2VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 2VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 3
(Date:5/17/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) ... brain may make the call on which ear you ... The dominant side of your brain is where your ... human population is left-brain dominant, and those people tend ... who are right-brain dominant. In this study, scientists found ...
(Date:5/17/2013)... 17, 2013 Fighting addiction is hard ... for diabetics, treatment is more difficult and complicated. Drug ... to monitor blood sugar levels and administer insulin when ... drug rehab for diabetics needs to have ... needs of the diabetic, and has experience caring for ...
(Date:5/17/2013)... 17 (HealthDay News) -- Teen bullies are more likely ... finds. UT Dallas researchers analyzed several decades of ... All of them had similar working-class backgrounds and most ... were in their mid-50s. Nearly half of the ... years engaged in some form of criminal activity -- ...
(Date:5/17/2013)... SportsFanPlayground.com is currently offering a new ... $319.99, nearly 20% off of the retail price. , The ... Adventures and Carnival Games, and a complementary 3-month Xbox Live ... Kinect Star Wars Bundle available for shipping. The Star Wars bundle ... 360 console, a custom white Kinect sensor, an Xbox 360 wired ...
(Date:5/17/2013)... Guide to the DSM-5 explores all revisions to ... Manual, and shows clinicians how they can best ... most contentious resource. Written by a celebrated professor ... and new research to point out where DSM-5 ... the jury,s still out. Along the way, The ...
Breaking Medicine News(10 mins):Health News:Cellphone Use May Reveal Your 'Dominant Brain' 2Health News:Cellphone Use May Reveal Your 'Dominant Brain' 3Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Xbox 360 Kinect Bundle 20% Off at SportsFanPlayground.com 2
... ... awake breast augmentation. This new cosmetic procure allows for breast augmentation without general anesthesia. ... ... York Times discussed a relatively new technique for augmenting breasts called Awake Breast Aug. Jane ...
... ... The Army has selected DOMA Technologies to provide Medical ... provide Business-To-Business remote coding services using their iCodeRx SaaS application and ... team will code, abstract, analyze and assemble medical record data and ...
... folks process input differently , SATURDAY, April 10 ... around them in a different way, introverted or shy ... other people, according to a new study. , About ... trait that can be seen in children who are ...
... ... of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis for 25,000 patients with nebulized ... ... in Westlake Village, California, is very proud to announce that it has reached an ...
... ... ... Arizona School of Health Sciences (ATSU-ASHS) held its spring commencement ceremony for four online ... a master of science or doctoral degree in Human Movement, Physician Assistant Studies, Audiology, and ...
... Researchers from the Children,s Cancer Hospital at The University ... a way to more accurately predict treatment outcomes in young ... blood count test, also known as a CBC. ... American Society of Pediatric Hematology Oncology,s (ASPHO) annual meeting today. ...
Cached Medicine News:Health News:Dr. Robert True Responds to a New York Time Article About a New Cosmetic Procedure Called Awake Breast Augmentation 2Health News:Army Awards Remote Medical Coding Contract to DOMA Technologies 2Health News:Shyness May Be Rooted in Brain Processing 2Health News:Sinus Dynamics Reaches Milestone with Treatment of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis Treating 25,000th Patient 2Health News:ATSU –ASHS Holds Spring Commencement Ceremony 2Health News:M. D. Anderson zeroes in on better way to predict prognosis in pediatric leukemia patients 2
Patient-Centered Therapy that promotes natural cardiac function....
... The Alliance Catheter Delivery ... manipulation, and stabilization of the ... Alliance CDS has a patented ... for quick and easy access ...
... throughout the world are facing difficult times ... of the blood supply in the face ... donor base. Clearly, these centers must find ... manage their existing donor pools, and to ...
The COBE 2991 Cell Processor provides reliable, automated cell processing, with the control you need to get reproducible results in your lab. This versatile machine offers users reliability and multi...
Medicine Products: